3d systems & theradaptive establish commercial partnership to advance orthopedic & soft tissue repair using breakthrough regenerative therapeutics

Rock hill, s.c. and frederick, md., aug. 07, 2023 (globe newswire) -- today, 3d systems (nyse:ddd), the leading additive manufacturing solutions partner, and theradaptive, a biopharmaceutical company breaking new ground in targeted regenerative therapeutics, announced they have entered a commercial agreement naming 3d systems as theradaptive's exclusive 3d printing partner. the companies intend to deliver a novel approach to promote bone and tissue growth using theradaptive's unique protein-based material-binding variants to coat 3d systems' 3d-printed medical devices. this solution has the potential to provide patients with an opportunity for improved healing and thus better outcomes.
DDD Ratings Summary
DDD Quant Ranking